Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087869642> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W3087869642 abstract "Ovarian cancer ranks first in the mortality causes pattern of female reproductive cancers in Russia. Treatment of relapsed ovarian cancer remains a significant challenge to practicing oncologists. Introduction of PARP inhibitors in clinical practice are the most significant achievements in this area. The use of drugs of this class significantly reduced the relative risk of tumour progression in relapsed ovarian cancer and increased the relapse-free duration. At the same time, many issues related to the practical use of PARP inhibitors remain unresolved. This review presents practical approaches to determining the categories of patients, who receive the greatest benefit from the use of drugs of this class. The article addresses epidemiology of BRCA-associated ovarian cancer. The authors presented information on modern methods for genetic testing, classification of mutations depending on proposed class of pathogenicity, and reviews the problems associated with identification of «variants of unknown clinical relevance». The mechanisms of action of PARP inhibitor are described in detail here. The evidence base demonstrating the efficacy and safety of olaparib, the only PARP inhibitor approved for clinical use in the Russian Federation as supportive therapy for platinum-sensitive relapsed BRCA-associated ovarian cancer, is discussed. The article detailed information on the spectrum of potential toxicity that is most commonly faced by oncologists prescribing olaparib and other PARP inhibitors. The main aspects of management of adverse events during olaparib therapy are also presented." @default.
- W3087869642 created "2020-10-01" @default.
- W3087869642 creator A5044208514 @default.
- W3087869642 creator A5091647374 @default.
- W3087869642 date "2019-12-09" @default.
- W3087869642 modified "2023-10-14" @default.
- W3087869642 title "Practical aspects of treating relapsed BRCA-associated ovarian cancer" @default.
- W3087869642 cites W1973037195 @default.
- W3087869642 cites W2002962154 @default.
- W3087869642 cites W2067893818 @default.
- W3087869642 cites W2084563311 @default.
- W3087869642 cites W2084985708 @default.
- W3087869642 cites W2125898467 @default.
- W3087869642 cites W2130078242 @default.
- W3087869642 cites W2135525536 @default.
- W3087869642 cites W2160466424 @default.
- W3087869642 cites W2168880218 @default.
- W3087869642 cites W2179105349 @default.
- W3087869642 cites W2243976116 @default.
- W3087869642 cites W2519148856 @default.
- W3087869642 cites W2528228811 @default.
- W3087869642 cites W2561042858 @default.
- W3087869642 cites W2737389832 @default.
- W3087869642 cites W2753122455 @default.
- W3087869642 cites W2754327139 @default.
- W3087869642 cites W2785810587 @default.
- W3087869642 cites W2883673963 @default.
- W3087869642 cites W2886743781 @default.
- W3087869642 cites W2896628407 @default.
- W3087869642 cites W2913584903 @default.
- W3087869642 cites W2957806526 @default.
- W3087869642 cites W4247883837 @default.
- W3087869642 doi "https://doi.org/10.21518/2079-701x-2019-19-144-149" @default.
- W3087869642 hasPublicationYear "2019" @default.
- W3087869642 type Work @default.
- W3087869642 sameAs 3087869642 @default.
- W3087869642 citedByCount "0" @default.
- W3087869642 crossrefType "journal-article" @default.
- W3087869642 hasAuthorship W3087869642A5044208514 @default.
- W3087869642 hasAuthorship W3087869642A5091647374 @default.
- W3087869642 hasBestOaLocation W30878696421 @default.
- W3087869642 hasConcept C121608353 @default.
- W3087869642 hasConcept C126322002 @default.
- W3087869642 hasConcept C143998085 @default.
- W3087869642 hasConcept C2780427987 @default.
- W3087869642 hasConcept C29456083 @default.
- W3087869642 hasConcept C71924100 @default.
- W3087869642 hasConceptScore W3087869642C121608353 @default.
- W3087869642 hasConceptScore W3087869642C126322002 @default.
- W3087869642 hasConceptScore W3087869642C143998085 @default.
- W3087869642 hasConceptScore W3087869642C2780427987 @default.
- W3087869642 hasConceptScore W3087869642C29456083 @default.
- W3087869642 hasConceptScore W3087869642C71924100 @default.
- W3087869642 hasLocation W30878696421 @default.
- W3087869642 hasLocation W30878696422 @default.
- W3087869642 hasOpenAccess W3087869642 @default.
- W3087869642 hasPrimaryLocation W30878696421 @default.
- W3087869642 hasRelatedWork W2069482181 @default.
- W3087869642 hasRelatedWork W2091020218 @default.
- W3087869642 hasRelatedWork W2130755392 @default.
- W3087869642 hasRelatedWork W2353260778 @default.
- W3087869642 hasRelatedWork W2365364931 @default.
- W3087869642 hasRelatedWork W2418638721 @default.
- W3087869642 hasRelatedWork W2789357466 @default.
- W3087869642 hasRelatedWork W2789448498 @default.
- W3087869642 hasRelatedWork W2897496508 @default.
- W3087869642 hasRelatedWork W3034140415 @default.
- W3087869642 isParatext "false" @default.
- W3087869642 isRetracted "false" @default.
- W3087869642 magId "3087869642" @default.
- W3087869642 workType "article" @default.